Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2

por Qin, Aiping, Mann, Barbara J
Publicado 2006

Adherence and uptake of Francisella into host cells

por Moreau, G Brett, Mann, Barbara J
Publicado 2013

Regulation of Kif15 localization and motility by the C-terminus of TPX2 and microtubule dynamics

por Mann, Barbara J., Balchand, Sai K., Wadsworth, Patricia
Publicado 2017

Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species

por Moreau, G. Brett, Qin, Aiping, Mann, Barbara J.
Publicado 2018

Azithromycin effectiveness against intracellular infections of Francisella

por Ahmad, Saira, Hunter, Lyman, Qin, Aiping, Mann, Barbara J, van Hoek, Monique L
Publicado 2010

Requirement of the CXXC Motif of Novel Francisella Infectivity Potentiator Protein B FipB, and FipA in Virulence of F. tularensis subsp. tularensis

por Qin, Aiping, Scott, David W., Rabideau, Meaghan M., Moore, Emily A., Mann, Barbara J.
Publicado 2011

Structure-Function Analysis of DipA, a Francisella tularensis Virulence Factor Required for Intracellular Replication

por Chong, Audrey, Child, Robert, Wehrly, Tara D., Rockx-Brouwer, Dedeke, Qin, Aiping, Mann, Barbara J., Celli, Jean
Publicado 2013

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection

por Moreau, Gregory Brett, Burgess, Stacey L., Sturek, Jeffrey M., Donlan, Alexandra N., Petri, William A., Mann, Barbara J.
Publicado 2020

Regulation of Virulence of Entamoeba histolytica by the URE3-BP Transcription Factor

por Gilchrist, Carol A., Moore, Ellyn S., Zhang, Yan, Bousquet, Christina B., Lannigan, Joanne A., Mann, Barbara J., Petri, William A.
Publicado 2010

Components of the type six secretion system are substrates of Francisella tularensis Schu S4 DsbA-like FipB protein

por Qin, Aiping, Zhang, Yan, Clark, Melinda E., Moore, Emily A., Rabideau, Meaghan M., Moreau, G. Brett, Mann, Barbara J.
Publicado 2016

Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

por Cunningham, Aimee L., Mann, Barbara J., Qin, Aiping, Santiago, Araceli E., Grassel, Christen, Lipsky, Michael, Vogel, Stefanie N., Barry, Eileen M.
Publicado 2020

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist()

por Mann, Barbara J., Chhabra, Preeti, Ma, Mingyang, Brovero, Savannah G., Hannan, Riley T., Sturek, Jeffrey M., Jones, Marieke K., Linden, Joel, Brayman, Kenneth L.
Publicado 2023

Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity

por Schutte, Kirsten M., Fisher, Debra J., Burdick, Marie D., Mehrad, Borna, Mathers, Amy J., Mann, Barbara J., Nakamoto, Robert K., Hughes, Molly A.
Publicado 2015

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates

por Santiago, Araceli E., Mann, Barbara J., Qin, Aiping, Cunningham, Aimee L., Cole, Leah E., Grassel, Christen, Vogel, Stefanie N., Levine, Myron M., Barry, Eileen M.
Publicado 2015

Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis

por O’Malley, Katherine J., Bowling, Jennifer L., Stinson, Elizabeth, Cole, Kelly S., Mann, Barbara J., Namjoshi, Prachi, Hazlett, Karsten R. O., Barry, Eileen M., Reed, Douglas S.
Publicado 2018

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

por Rabin, Joseph, Zhao, Yunge, Mostafa, Ezzat, Al-Suqi, Manal, Fleischmann, Emily, Conaway, Mark R., Mann, Barbara J., Chhabra, Preeti, Brayman, Kenneth L., Krupnick, Alexander, Linden, Joel, Lau, Christine L.
Publicado 2023

Targets of the Entamoeba histolytica Transcription Factor URE3-BP

por Gilchrist, Carol A., Baba, Duza J., Zhang, Yan, Crasta, Oswald, Evans, Clive, Caler, Elisabet, Sobral, Bruno W. S., Bousquet, Christina B., Leo, Megan, Hochreiter, Ameilia, Connell, Sarah K., Mann, Barbara J., Petri, William A.
Publicado 2008

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant

por Abhyankar, Mayuresh M., Mann, Barbara J., Sturek, Jeffrey M., Brovero, Savannah, Moreau, G. Brett, Sengar, Anjali, Richardson, Crystal M., Agah, Sayeh, Pomés, Anna, Kasson, Peter M., Tomai, Mark A., Fox, Christopher B., Petri, William A.
Publicado 2021

Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection

por Keshavarz, Behnam, Richards, Nathan E., Workman, Lisa J., Patel, Jaimin, Muehling, Lyndsey M., Canderan, Glenda, Murphy, Deborah D., Brovero, Savannah G., Ailsworth, Samuel M., Eschenbacher, Will H., McGowan, Emily C., Mann, Barbara J., Nelson, Michael R., Kadl, Alexandra, Woodfolk, Judith A., Platts-Mills, Thomas A.E., Wilson, Jeffrey M.
Publicado 2022

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19

por Zhu, Bibo, Wei, Xiaoqin, Narasimhan, Harish, Qian, Wei, Zhang, Ruixuan, Cheon, In Su, Wu, Yue, Li, Chaofan, Jones, Russell G., Kaplan, Mark H., Vassallo, Robert A., Braciale, Thomas J., Somerville, Lindsay, Colca, Jerry R., Pandey, Akhilesh, Jackson, Patrick E. H., Mann, Barbara J., Krawczyk, Connie M., Sturek, Jeffrey M., Sun, Jie
Publicado 2023